手术医生类型与住院踝关节融合术及全踝关节置换术后的结局:基于全国Premier医疗索赔数据库的回顾性队列研究
该回顾性队列研究利用2011至2016年全国Premier医疗索赔数据库,比较足踝骨科医生与足病医生实施全踝关节置换术(n=3,674)和踝关节融合术(n=4,980)的结局。调整协变量后,足病医生实施的手术与住院时间延长相关,踝关节融合术还与住院费用增加相关;阿片类药物利用差异无统计学意义。足病医生实施手术的比例从2011年至2016年呈上升趋势。
要点
- 足病医生实施的全踝关节置换术住院时间较足踝骨科医生增加16.7%(95%CI 7.6%至26.5%)。
- 足病医生实施的踝关节融合术住院时间增加14.2%(95%CI 7.9%至20.9%),费用增加28.5%(95%CI 22.1%至35.2%)。
- 阿片类药物利用差异无统计学意义,全踝关节置换术+10.9%(95%CI -3.1%至26.8%),踝关节融合术+2.8%(95%CI -5.9%至12.4%)。
核心结论
- 足病医生实施手术的比例呈上升趋势,并与住院时间和费用 apparent 增加相关,但阿片类药物利用差异无统计学意义。
研究设计与样本
- 回顾性队列研究,使用2011至2016年全国Premier医疗索赔数据库,纳入全踝关节置换术(n=3,674)和踝关节融合术(n=4,980)病例。
- 采用多变量模型估计手术医生类型(足病医生 vs 足踝骨科医生)与阿片类药物利用(口服吗啡当量[OMEs])、住院时间和住院费用的关联,报告变化百分比(与参照组比较)及95%置信区间。
主要发现
- 全踝关节置换术中,76.5%(n=2,812)由足踝骨科医生实施,18.8%(n=690)由足病医生实施,4.7%(n=172)医生类型未知。
- 踝关节融合术中,75.3%(n=3,752)由足踝骨科医生实施,18.3%(n=912)由足病医生实施,6.3%(n=316)医生类型未知。
- 足病医生实施的全踝关节置换术比例从2011年12.8%升至2016年24.6%,踝关节融合术从13.6%升至26.0%。
- 调整协变量后,足病医生实施的全踝关节置换术住院时间增加16.7%(95%CI 7.6%至26.5%;两组中位住院时间均为2天),踝关节融合术住院时间增加14.2%(95%CI 7.9%至20.9%;中位住院时间3天 vs 2天),均p<0.05。
- 足病医生实施的踝关节融合术住院费用增加28.5%(95%CI 22.1%至35.2%;中位费用19,236美元 vs 13,433美元),p<0.05。
关键数值与推荐
- 足病医生实施的全踝关节置换术住院时间较足踝骨科医生增加16.7%(95%CI 7.6%至26.5%),p<0.05。
- 足病医生实施的踝关节融合术住院时间增加14.2%(95%CI 7.9%至20.9%),p<0.05。
- 足病医生实施的踝关节融合术住院费用增加28.5%(95%CI 22.1%至35.2%),p<0.05。
- 阿片类药物利用差异无统计学意义:全踝关节置换术+10.9%(95%CI -3.1%至26.8%),踝关节融合术+2.8%(95%CI -5.9%至12.4%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two main treatments for end-stage ankle arthritis are ankle arthrodesis and total ankle arthroplasty (TAA). While both procedures can be performed either by a foot and ankle orthopaedic surgeon or a podiatrist (when within a particular state's scope of practice), studies comparing the surgical outcomes of the 2 surgeon types are lacking. Therefore, in this study, we compared outcomes by surgeon type for TAA and for ankle arthrodesis. METHODS: This retrospective cohort study utilized data from the nationwide Premier Healthcare claims database (2011 to 2016) regarding TAA (n = 3,674) and ankle arthrodesis (n = 4,980) procedures. Multivariable models estimated associations between surgeon type (podiatrist versus orthopaedic foot and ankle surgeon) and opioid utilization (in oral morphine equivalents [OMEs]), length of stay, and cost of hospitalization. We report percent change (compared with reference) and 95% confidence intervals (CIs). RESULTS: Overall, 76.5% (n = 2,812) and 18.8% (n = 690) of TAA procedures were performed by orthopaedic foot and ankle surgeons and podiatrists, respectively; surgeon type was unknown for 4.7% (n = 172). For ankle arthrodesis, 75.3% (n = 3,752) and 18.3% (n = 912) of the procedures were performed by orthopaedic foot and ankle surgeons and podiatrists, respectively; surgeon type was unknown for 6.3% (n = 316). The proportion of TAA and ankle arthrodesis procedures performed by podiatrists increased over time, from 12.8% and 13.6% in 2011 to 24.6% and 26.0% in 2016, respectively. When adjusting for relevant covariates, procedures performed by podiatrists (compared with orthopaedic foot and ankle surgeons) were associated with increased length of stay: for TAA, +16.7% (95% CI, 7.6% to 26.5%; median, 2 days in both groups) and for ankle arthrodesis, +14.2% (95% CI, 7.9% to 20.9%; median, 3 compared with 2 days) (p < 0.05 for both). In addition, ankle arthrodesis performed by podiatrists was associated with increased cost of hospitalization: +28.5% (95% CI, 22.1% to 35.2%; median, $19,236 compared with $13,433) (p < 0.05). Differences in opioid utilization were nonsignificant in the main analysis: +10.9% (95% CI, -3.1% to 26.8%; median, 345 compared with 250 OMEs) and +2.8% (95% CI, -5.9% to 12.4%; median, 351 compared with 315 OMEs) for TAA and ankle arthrodesis, respectively. CONCLUSIONS: An increasing trend in the proportion of procedures performed by podiatrists was coupled with apparent increases in length of stay and cost compared with procedures performed by orthopaedic foot and ankle surgeons. Given the increasing demand for these procedures, factors associated with resource utilization, such as type of surgeon, may be increasingly important on the population level. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Chan JJ, Chan JC, Poeran J, et al. Surgeon Type and Outcomes After Inpatient Ankle Arthrodesis and Total Ankle Arthroplasty: A Retrospective Cohort Study Using the Nationwide Premier Healthcare Claims Database. J Bone Joint Surg Am. 2019. PMID: 30653042. doi:10.2106/JBJS.17.01555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。